デフォルト表紙
市場調査レポート
商品コード
1666170

人工膝関節置換術の世界市場:2025年~2033年

Global Knee Replacement Market - 2025-2033


出版日
ページ情報
英文 220 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
人工膝関節置換術の世界市場:2025年~2033年
出版日: 2025年02月24日
発行: DataM Intelligence
ページ情報: 英文 220 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の人工膝関節置換術の市場規模は、特に高齢者層において、膝の機能に影響を及ぼす変性関節疾患である変形性膝関節症の有病率の増加が牽引しています。世界人口の高齢化に伴い、慢性的な膝の痛みや運動機能の低下といった関節関連の問題が増加し、人工膝関節置換術の需要が高まっています。認知度の向上、外科手術の進歩、インプラント材料の改良が、これらの機器の世界の普及をさらに加速させています。

例えば、変形性関節症(OA)は最も一般的な関節炎であり、全世界で約5億人、人口の7%が罹患しています。米国では3,200万人以上がOAを患っています。この疾患は高齢者や女性に多く、その他にも怪我、肥満、遺伝などの危険因子があります。

インプラント装置、入院費、手術料、リハビリテーション、術後ケアなど、人工膝関節置換術の費用が高いことが市場の大きな抑制要因となっています。これは、ヘルスケア・インフラが限られている地域や保険適用が不十分な地域では特に課題となります。新興諸国では、手ごろな価格のヘルスケアの選択肢や高度な手術施設へのアクセスがないため、人工膝関節置換術の採用がさらに制限されています。

当レポートでは、世界の人工膝関節置換術市場について調査し、市場の概要とともに、手技タイプ別、インプラントタイプ別、コンポーネント別、固定タイプ別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第5章 戦略的洞察と業界の展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第6章 手技タイプ別

  • 膝関節全置換術
  • 部分膝関節置換術
  • 膝関節置換術の再手術

第7章 インプラントタイプ別

  • 固定ベアリングインプラント
  • 可動ベアリングインプラント
  • 内側ピボットインプラント
  • カスタマイズインプラント

第8章 コンポーネント別

  • 大腿骨コンポーネント
  • 脛骨コンポーネント
  • 膝蓋骨コンポーネント

第9章 固定タイプ別

  • セメント固定
  • セメントレス固定
  • ハイブリッド固定

第10章 エンドユーザー別

  • 病院
  • 外来手術センター(ASC)
  • 整形外科クリニック
  • リハビリテーションセンター

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • 南米
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第12章 競合情勢

第13章 企業プロファイル

  • Zimmer Biomet Holdings, Inc
  • Stryker Corporation
  • DePuy Synthes(Johnson &Johnson)
  • Smith &Nephew Plc
  • B. Braun Melsungen AG
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Exactech, Inc
  • Conformis, Inc
  • DJO Global, Inc
  • Similar data will be provided for each market player.
  • Aesculap Implant Systems, LLC
  • Medacta International SA
  • Corin Group
  • Think Surgical, Inc

第14章 付録

目次
Product Code: MD9156

The Global Knee Replacement Market reached US$ 10.85 Billion in 2024 and is expected to reach US$ 16.72 Billion by 2033, growing at a CAGR of 4.8% during the forecast period 2025-2033.

Knee Replacement Devices are medical implants designed to replace damaged or diseased parts of the knee joint, often due to conditions like osteoarthritis or rheumatoid arthritis. They aim to restore mobility, reduce pain, and improve knee joint function, and are commonly used in surgical procedures like total or partial knee replacements.

Market Dynamics: Drivers & Restraints

Growing Prevalence of Osteoarthritis

The global knee replacement market is driven by the increasing prevalence of osteoarthritis, a degenerative joint disease affecting knee function, especially in the elderly population. As the global population ages, joint-related issues like chronic knee pain and reduced mobility increase, leading to a higher demand for knee replacement procedures. Increased awareness, surgical advancements, and improved implant materials have further accelerated the adoption of these devices globally.

For instance, Osteoarthritis (OA) is the most common form of arthritis, affecting around 500 million people globally, or 7% of the population. In the US, over 32 million people have OA. The condition is more common among older adults and females, with other risk factors including injury, obesity, and genetics. This article discusses the prevalence of OA in the US and worldwide, its effects, causes, effects, and prevention methods. It also explores ways to help prevent the condition.

High Cost of Knee Replacement Procedures

The high cost of knee replacement surgeries, including implant devices, hospital charges, surgical fees, rehabilitation, and post-operative care, is a significant restraint in the market. This is particularly challenging in regions with limited healthcare infrastructure or inadequate insurance coverage. In developing countries, the lack of affordable healthcare options and access to advanced surgical facilities further restricts the adoption of knee replacement devices.

Segment Analysis

The global Knee Replacement market is segmented based on Procedure Type, Implant Type, Component, Fixation Type, End User and Region.

Procedure Type:

Total Knee Replacement segment is expected to dominate the Knee Replacement market share

The Total Knee Replacement segment holds a major portion of the knee replacement market share and is expected to continue to hold a significant portion of the knee replacement market share during the forecast period.

Total Knee Replacement (TKR) is a surgical procedure that replaces a damaged or diseased knee joint with an artificial prosthesis, often recommended for severe knee pain from conditions like osteoarthritis, rheumatoid arthritis, or traumatic injuries. The procedure involves replacing the femoral, tibial, and patellar components of the knee with metal, plastic, or ceramic implants. The goal is to alleviate pain, improve mobility, and restore knee joint functionality, allowing patients to return to daily activities and improve their quality of life.

For instance, in June 2024, Meril, an India-based medical device company, has launched its indigenously developed advanced surgical robotic technology, MISSO, which will assist doctors in real-time knee replacement procedures. This technology will reduce the investment required for knee replacement surgeries by 66%, making them more accessible and affordable. Meril plans to adapt this technology for other joint surgeries in the future.

End User:-

Hospitals segment is the fastest-growing segment in Knee Replacement market share

The hospitals segment is the fastest-growing segment in the Knee Replacement market share and is expected to hold the market share over the forecast period.

Hospitals are vital in the Total Knee Replacement (TKR) procedure due to their infrastructure, specialized medical staff, and postoperative care. They use advanced diagnostic tools to assess knee damage severity and perform the procedure using advanced surgical techniques and implant technologies. Post-surgery, hospitals offer comprehensive rehabilitation programs to help patients regain strength, flexibility, and function. They also monitor patients for potential complications and provide pain management options. A multidisciplinary care approach is essential for achieving optimal results in TKR surgeries.

For instance, in November 2024, Lower Bucks Hospital has introduced Persona IQ, the first smart knee implant to receive De Novo classification from the U.S. Food and Drug Administration for total knee replacement procedures. This innovative implant integrates the Persona Personalized Knee with advanced implantable sensor technology, measuring range of motion, step count, walking speed, and other vital gait metrics.

Moreover, in January 2024, Omega Hospitals, Gachibowli, has successfully performed a knee replacement surgery on a 60-year-old woman using 3D augmented realty glasses, a proprietary technology from France. The technology, which uses computer navigation solutions, helped achieve accurate limb alignment, reduced blood loss, smaller incisions, and facilitated early recovery, according to Dr Aditya Kapoor, Director of Orthopaedics at the hospital.

Geographical Analysis

North America is expected to hold a significant position in the Knee Replacement market share

North America holds a substantial position in the Knee Replacement market and is expected to hold most of the market share due to high prevalence of osteoarthritis and degenerative joint diseases, as well as the aging population and rising obesity rates. The region's advanced healthcare infrastructure, well-established reimbursement policies, and access to advanced surgical technologies like robotic-assisted knee replacement systems support market growth. The strong focus on research and development, key market players, and high patient awareness accelerate the adoption of knee replacement implants in North America.

For instance, according to Bone and Joint Canada, currently in Canada, there are more than 4.6 million OA patients, which in another generation (30 years from now) would rise to more than 10 million-or one in four.

Moreover, in November 2024, Zimmer Biomet Holdings has received FDA Premarket Approval Application Supplement approval for the Oxford Cementless Partial Knee. The approval is based on safety and effectiveness data from an Investigational Device Exemption study and non-clinical testing for cementless partial knee replacement (PKR). The Oxford Cementless Partial Knee offers improved fixation, long-term implant survival rate, and operating room efficiency compared to the Oxford Cemented Partial Knee procedure.

Europe is growing at the fastest pace in the Knee Replacement market

Europe holds the fastest pace in the Knee Replacement market and is expected to hold most of the market share due to increasing aging populations, osteoarthritis, and increased awareness about joint health. With robust healthcare systems and technological advancements, knee replacement surgeries are more accessible to a larger population. Government initiatives, leading orthopedic companies, and strong regulatory support through CE certifications further drive the market's growth. Technological advancements, minimally invasive surgical techniques, and post-operative rehabilitation programs also contribute to improved patient outcomes.

For instance, in June 2024, Corin, a leading robotics and AI innovator in orthopaedics, has launched its ApolloKnee surgical application and Apollo platform for robotic-assisted total knee arthroplasty. The applications have received regulatory clearance in all major markets and have been used to objectively balance knees in over 200 patients. Corin's CEO, Jon Serbousek, praised the success of the early release as a testament to their cross-functional teams and scalable manufacturing capabilities.

Competitive Landscape

The major global players in the Knee Replacement market include Zimmer Biomet Holdings, Inc, Stryker Corporation, DePuy Synthes (Johnson & Johnson), Smith & Nephew Plc, B. Braun Melsungen AG, Medtronic Plc, MicroPort Scientific Corporation, Exactech, Inc, Conformis, Inc, DJO Global, Inc and among others.

Key Developments

  • In February 2025, Meril, an India-based medical device company, has launched its indigenously developed advanced surgical robotic technology, MISSO, which will assist doctors during knee replacement procedures in real-time. MISSO will reduce the investment required for knee replacement surgeries by 66%, making them more accessible and affordable. The technology can be adapted for other joint surgeries in the future.
  • In October 2024, Exactech has received FDA clearance for its Truliant Porous Tibial Tray, a 3D tibial knee implant. The device uses additive manufacturing to create a porous structure mimicking cancellous bone, facilitating both initial and biological fixation, and accommodating patients' active lifestyles.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Knee Replacement market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Procedure Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Procedure Type
  • 3.2. Snippet by Implant Type
  • 3.3. Snippet by Component
  • 3.4. Snippet by Fixation Type
  • 3.5. Snippet by End User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Prevalence of Osteoarthritis
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Knee Replacement Procedures
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Procedure Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 6.1.2. Market Attractiveness Index, By Procedure Type
  • 6.2. Total Knee Replacement*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Partial Knee Replacement
  • 6.4. Revision Knee Replacement

7. By Implant Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implant Type
    • 7.1.2. Market Attractiveness Index, By Implant Type
  • 7.2. Fixed-Bearing Implants*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Mobile-Bearing Implants
  • 7.4. Medial Pivot Implants
  • 7.5. Customized Implants

8. By Component

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 8.1.2. Market Attractiveness Index, By Component
  • 8.2. Femoral Component*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Tibial Component
  • 8.4. Patellar Component

9. By Fixation Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Type
    • 9.1.2. Market Attractiveness Index, By Fixation Type
  • 9.2. Cemented Fixation*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Cementless Fixation
  • 9.4. Hybrid Fixation

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory Surgical Centers (ASCs)
  • 10.4. Orthopedic Clinics
  • 10.5. Rehabilitation Centers

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implant Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Type
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. U.S.
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implant Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Type
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. U.K.
      • 11.3.8.3. France
      • 11.3.8.4. Spain
      • 11.3.8.5. Italy
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implant Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Type
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Brazil
      • 11.4.8.2. Argentina
      • 11.4.8.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implant Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Type
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. South Korea
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implant Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Type
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

Key Market Players

  • 13.1. Zimmer Biomet Holdings, Inc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio
      • 13.1.2.1. Product Description
      • 13.1.2.2. Product Key Performance Indicators (KPIs)
      • 13.1.2.3. Historic and Forecasted Product Sales
      • 13.1.2.4. Product Sales Volume
    • 13.1.3. Financial Overview
      • 13.1.3.1. Company Revenue's
      • 13.1.3.2. Geographical Revenue Shares
      • 13.1.3.3. Revenue Forecasts
    • 13.1.4. Key Developments
      • 13.1.4.1. Mergers & Acquisitions
      • 13.1.4.2. Key Product Development Activities
      • 13.1.4.3. Regulatory Approvals etc.
    • 13.1.5. SWOT Analysis
  • 13.2. Stryker Corporation
  • 13.3. DePuy Synthes (Johnson & Johnson)
  • 13.4. Smith & Nephew Plc
  • 13.5. B. Braun Melsungen AG
  • 13.6. Medtronic Plc
  • 13.7. MicroPort Scientific Corporation
  • 13.8. Exactech, Inc
  • 13.9. Conformis, Inc
  • 13.10. DJO Global, Inc
  • Similar data will be provided for each market player.

Emerging Market Players

  • 13.11. Aesculap Implant Systems, LLC*
    • 13.11.1. Pipeline Products Description
    • 13.11.2. Product Key Performance Indicators (KPIs)
    • 13.11.3. Key Activities
    • 13.11.4. Market Entry Timelines
    • 13.11.5. Product Penetration Rate
    • 13.11.6. Sales Estimation and Projections
  • 13.12. Medacta International SA
  • 13.13. Corin Group
  • 13.14. Think Surgical, Inc
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us